Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKYA NASDAQ:FEIM NASDAQ:KEQU NASDAQ:MASS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.29$1.24$0.93▼$3.42$64.44M1.36412,434 shsN/AFEIMFrequency Electronics$21.47+5.3%$20.02$9.27▼$24.77$197.21M0.47118,599 shs351,295 shsKEQUKewaunee Scientific$55.65-1.9%$44.69$30.33▼$71.33$167.18M0.722,214 shs4,477 shsMASS908 Devices$6.70-1.2%$6.34$1.81▼$8.06$243.14M0.381.06 million shs217,895 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%0.00%+3.20%+18.89%-50.38%FEIMFrequency Electronics+3.40%-10.10%-8.73%+17.94%+119.85%KEQUKewaunee Scientific-2.79%-3.03%+54.24%+69.65%+11.24%MASS908 Devices+1.65%-6.09%-7.76%+42.89%+11.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKYAAkoya Biosciences2.35 of 5 stars3.03.00.00.02.71.70.6FEIMFrequency Electronics1.3936 of 5 stars0.03.00.00.01.92.51.3KEQUKewaunee Scientific0.9808 of 5 stars0.02.00.00.03.30.81.3MASS908 Devices1.1288 of 5 stars1.31.00.00.01.95.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKYAAkoya Biosciences 2.00Hold$2.5194.26% UpsideFEIMFrequency Electronics 0.00N/AN/AN/AKEQUKewaunee Scientific 0.00N/AN/AN/AMASS908 Devices 2.50Moderate Buy$5.33-20.40% DownsideCurrent Analyst Ratings BreakdownLatest AKYA, MASS, FEIM, and KEQU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/12/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)6/27/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)6/11/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (D-)5/24/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (E+)5/19/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.80 ➝ $1.085/10/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)4/29/2025AKYAAkoya BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$3.50 ➝ $1.804/24/2025MASS908 DevicesWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (D-) ➝ Sell (D-)(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKYAAkoya Biosciences$79.96M0.81N/AN/A$0.15 per share8.60FEIMFrequency Electronics$69.81M2.98$0.86 per share25.05$4.20 per share5.11KEQUKewaunee Scientific$240.47M0.68$7.21 per share7.72$23.21 per share2.40MASS908 Devices$59.63M4.03N/AN/A$3.29 per share2.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKYAAkoya Biosciences-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)FEIMFrequency Electronics$23.80M$2.478.69∞N/A34.09%58.90%28.74%7/21/2025 (Estimated)KEQUKewaunee Scientific$11.40M$3.8314.53∞N/A4.74%26.02%9.87%9/10/2025 (Estimated)MASS908 Devices-$72.21M-$0.540.00N/AN/A-28.80%-27.10%-20.49%8/5/2025 (Estimated)Latest AKYA, MASS, FEIM, and KEQU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025MASS908 Devices-$0.16N/AN/AN/A$12.17 millionN/A8/4/2025Q2 2025AKYAAkoya Biosciences-$0.22N/AN/AN/A$18.10 millionN/A7/10/2025Q4 2025FEIMFrequency ElectronicsN/A$0.34N/A$0.34N/A$19.99 million6/25/2025Q4 2025KEQUKewaunee ScientificN/A$1.95N/A$1.63N/A$77.15 million5/13/2025Q1 2025MASS908 Devices-$0.27-$0.22+$0.05$1.23$11.90 million$11.78 million5/12/2025Q1 2025AKYAAkoya Biosciences-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKYAAkoya BiosciencesN/AN/AN/AN/AN/AFEIMFrequency ElectronicsN/AN/AN/AN/AN/AKEQUKewaunee ScientificN/AN/AN/AN/AN/AMASS908 DevicesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKYAAkoya Biosciences10.120.610.40FEIMFrequency ElectronicsN/A2.191.08KEQUKewaunee Scientific0.922.201.59MASS908 DevicesN/A7.626.97Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKYAAkoya Biosciences79.42%FEIMFrequency Electronics58.60%KEQUKewaunee Scientific32.69%MASS908 Devices88.06%Insider OwnershipCompanyInsider OwnershipAKYAAkoya Biosciences7.30%FEIMFrequency Electronics26.10%KEQUKewaunee Scientific13.30%MASS908 Devices23.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKYAAkoya Biosciences9049.95 million46.31 millionOptionableFEIMFrequency Electronics2009.68 million7.15 millionNot OptionableKEQUKewaunee Scientific1,2392.95 million2.56 millionNot OptionableMASS908 Devices6035.86 million27.36 millionOptionableAKYA, MASS, FEIM, and KEQU HeadlinesRecent News About These CompaniesBrokers Offer Predictions for 908 Devices FY2027 EarningsJuly 18 at 11:38 AM | marketbeat.comFavourable Signals For 908 Devices: Numerous Insiders Acquired StockJuly 16 at 10:53 PM | finance.yahoo.com908 Devices (NASDAQ:MASS) Given Sell (D-) Rating at Weiss RatingsJuly 15 at 2:23 AM | americanbankingnews.com908 Devices (NASDAQ:MASS) Receives "Sell (D-)" Rating from Weiss RatingsJuly 14, 2025 | marketbeat.com908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk SubstancesJuly 9, 2025 | finance.yahoo.comSumitomo Mitsui Trust Group Inc. Cuts Holdings in 908 Devices Inc. (NASDAQ:MASS)July 5, 2025 | marketbeat.com908 Devices Inc Share Price | NASDAQ: MASS Stock - Investing.com UKJune 29, 2025 | uk.investing.com908 Devices (NASDAQ:MASS) Given "Sell (D-)" Rating at Weiss RatingsJune 28, 2025 | marketbeat.comMasivo Highlights Wide Historic High-Grade Results from Cerro Colorado and Announces Equity RaiseJune 27, 2025 | newsfilecorp.comN908 Devices (MASS) Upgraded to Buy: Here's What You Should KnowJune 26, 2025 | zacks.comAsylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500June 25, 2025 | businesswire.com908 Devices Inc. (NASDAQ:MASS) Insider Michael S. Turner Sells 1,373 SharesJune 19, 2025 | insidertrades.com908 Devices Inc. (NASDAQ:MASS) Insider Michael S. Turner Sells 1,373 SharesJune 18, 2025 | marketbeat.com908 Devices Inc. (NASDAQ:MASS) Insider Michael S. Turner Sells 7,148 SharesJune 18, 2025 | marketbeat.com908 Devices Inc. (NASDAQ:MASS) Insider Sells $120,775.82 in StockJune 18, 2025 | marketbeat.com908 Devices Appoints Christopher D. Brown to its Board of DirectorsJune 17, 2025 | finance.yahoo.com908 Devices Inc. (NASDAQ:MASS) CFO Joseph H. Iv Griffith Sells 6,940 SharesJune 7, 2025 | insidertrades.comMetropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response ToolkitJune 3, 2025 | tmcnet.comWhy 908 Devices Stock Rocketed More Than 18% Higher This WeekMay 30, 2025 | fool.comAll You Need to Know About 908 Devices (MASS) Rating Upgrade to BuyMay 26, 2025 | zacks.com908 Devices to Participate in the William Blair 45th Annual Growth Stock ConferenceMay 22, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Overbought Stocks Ripe for a PullbackBy Ryan Hasson | July 7, 2025View 3 Overbought Stocks Ripe for a PullbackAI Infrastructure Is Exploding—Don’t Overlook CoreWeave & NebiusBy Jeffrey Neal Johnson | July 17, 2025View AI Infrastructure Is Exploding—Don’t Overlook CoreWeave & NebiusBelieve the Hype? Can SoFi Maintain Its 3-Month Rally?By Nathan Reiff | July 8, 2025View Believe the Hype? Can SoFi Maintain Its 3-Month Rally?Geospace Stock Skyrockets After Major Petrobras ContractBy Jeffrey Neal Johnson | June 24, 2025View Geospace Stock Skyrockets After Major Petrobras ContractSpotify's Massive Rally: Can New Features Sustain the Momentum?By Nathan Reiff | June 27, 2025View Spotify's Massive Rally: Can New Features Sustain the Momentum?AKYA, MASS, FEIM, and KEQU Company DescriptionsAkoya Biosciences NASDAQ:AKYA$1.29 0.00 (0.00%) As of 07/8/2025Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.Frequency Electronics NASDAQ:FEIM$21.47 +1.09 (+5.35%) Closing price 04:00 PM EasternExtended Trading$21.44 -0.02 (-0.12%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.Kewaunee Scientific NASDAQ:KEQU$55.65 -1.08 (-1.90%) Closing price 04:00 PM EasternExtended Trading$55.56 -0.09 (-0.16%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.908 Devices NASDAQ:MASS$6.70 -0.08 (-1.18%) Closing price 04:00 PM EasternExtended Trading$6.70 +0.00 (+0.07%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.